E159: The Bestie Awards! Recapping the best and worst of 2023
TL;DR
- The All-In panel debates the biggest political winners and losers of 2023, including discussions on RFK Jr., third-party politics, and Ukraine's continued relevance
- Major business winners included Microsoft and AI-driven companies, while Uber faced challenges and ESG markets experienced significant decline
- The FDA's approval of the first CRISPR gene-editing drug for sickle cell disease was highlighted as the year's biggest science breakthrough
- Meta's stock recovery and CEO leadership changes across major corporations were recognized as significant business developments
- The panel discusses cultural trends including the best memes, new technologies like advanced AI models, and major media moments from 2023
- Awards categories include recognition of worst companies, turnaround stories, and cultural phenomena like the 'Rudy Giuliani Award for Self-Immolation'
Episode Recap
In the fourth annual Bestie Awards episode, the All-In Podcast panel celebrates and critiques the biggest winners, losers, and surprises across politics, business, science, and culture from 2023. The conversation opens with political analysis, debating who emerged as the year's biggest political winner and loser. The panel discusses Volodymyr Zelensky's continued prominence following his Time Magazine Person of the Year recognition, while also exploring the shifting landscape of American politics, including RFK Jr.'s favorability rankings and growing support for third-party candidates according to recent Gallup polling.
In the business segment, Microsoft emerges as a clear winner, benefiting from the AI revolution and ChatGPT's explosive growth. The hosts analyze why certain tech giants thrived while others struggled, examining Uber's challenges and the broader contraction of the ESG market by billions of dollars. Meta's remarkable stock recovery receives particular attention as a turnaround story that surprised many observers.
The science breakthrough category focuses on the FDA's historic approval of the world's first CRISPR gene-editing drug for sickle cell disease, representing a major milestone in medical technology. The panel discusses what this means for the future of genetic medicine and disease treatment.
Beyond these major categories, the episode covers CEO performances, investor achievements, and company failures. The discussion extends into cultural commentary with segments devoted to the best memes of 2023, emerging technologies, and prevailing trends that defined the year. The hosts debate what counted as merely a flash in the pan versus genuine lasting innovations.
A notable award category includes the Rudy Giuliani Award for Self-Immolation, which recognizes public figures whose decisions led to dramatic reversals of fortune or credibility. This playful yet insightful category allows the panel to comment on notable downfalls and self-sabotaging decisions made by prominent figures throughout the year.
The conversation reflects the panel's characteristic blend of irreverent commentary and substantive analysis. They apply their venture capital and business expertise to evaluate trends, while also engaging with broader cultural moments and political developments. The episode serves as both entertainment and a retrospective lens on major 2023 events, providing the panel's curated perspective on what mattered most across multiple domains.
Key Moments
Notable Quotes
“This fourth annual Bestie Awards captures what really mattered in 2023 across business, politics, and culture”
“The CRISPR approval for sickle cell disease represents one of the most significant breakthroughs in medicine we've seen”
“Microsoft's dominance in 2023 was driven by their early positioning in the AI revolution”
“We're seeing a real shift in American politics with growing support for third-party candidates”
“Meta's turnaround story reminds us that even major tech companies can face existential challenges and recover”
Products Mentioned
Full Transcript▼
